Mitochondrial Encephalomyopathies and Mental Retardation: Investigations of Clinical Syndromes Associated With MtDNA Point Mutations

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Carriers of the m.3242A\>G mutation often have clinical symptoms which can include migraines, seizures, strokes, hearing loss, balance issues, gastrointestinal issues, and many other symptoms. The investigators would like to learn more about these disorders and have designed a Natural History Study to monitor these conditions over time so that physicians and scientists can not only understand the problems that patients have, but work on developing treatments. The focus of the current work is to evaluate known mutation carriers of the m.3243A\>G (mitochondrial DNA) and their maternal relatives (carrier status not a requirement for participation). Paternal relatives will serve as controls. This study involves no treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Healthy Volunteers: t
View:

• Known carrier of a the m.3243 A\>G mitochondrial mutation, ,or Maternally related to someone who carries the m.3243A\>G mitochondrial mutation.

• A family member who is not maternally related to someone who carries the m.3243A\>G mitochondrial mutation

Locations
United States
New York
Columbia University
RECRUITING
New York
Contact Information
Primary
Kris Engelstad, MS
ke4@cumc.columbia.edu
2123056834
Backup
Darryl De Vivo, MD
dcd1@cumc.columbia.edu
2123055244
Time Frame
Start Date: 2004-07
Estimated Completion Date: 2025-07
Participants
Target number of participants: 300
Treatments
mtDNA mutation
m.3243 A\>G carriers and their maternal relatives Other mutations in the mitochondrial genome may be included
Control
controls (people not maternally related to mutation carriers) Preference is for married in relatives
Sponsors
Leads: Columbia University
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

This content was sourced from clinicaltrials.gov